Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309269323> ?p ?o ?g. }
- W4309269323 endingPage "2487" @default.
- W4309269323 startingPage "2487" @default.
- W4309269323 abstract "Recently, the United States Food and Drug Administration published a series of product-specific guidance for the development of topical drugs, with in vitro options consisting of qualitative sameness (Q1) and quantitative sameness (Q2) assessment of formulations, physiochemical and structural characterization of formulations (Q3), and, potentially, in vitro drug release and permeation tests. In these tests, the topical semisolid product's critical quality attributes (CQAs), such as rheological properties, thermodynamic activity, particle size, globule size, and rate/extent of drug release/permeation, are evaluated to ensure the desired product quality. However, alterations in these CQAs of the drug products may occur under 'in use' conditions because of various metamorphosis events, such as evaporation that leads to supersaturation and crystallization, which may eventually result in specific failure modes of semisolid products. Under 'in use' conditions, a limited amount of formulation is applied to the skin, where physicochemical characteristics of the formulation are substantially altered from primary state to secondary and, eventually, tertiary state on the skin. There is an urgent need to understand the behavior of topical semisolid products under 'in use' conditions. In this review, we attempt to cover a series of metamorphosis events and their impact on CQAs (Q3 attributes), such as viscosity, drug activity, particle size, globule size, and drug release/permeation of topical semisolid products." @default.
- W4309269323 created "2022-11-25" @default.
- W4309269323 creator A5010374654 @default.
- W4309269323 creator A5051641480 @default.
- W4309269323 creator A5062328378 @default.
- W4309269323 date "2022-11-17" @default.
- W4309269323 modified "2023-10-14" @default.
- W4309269323 title "Topical Semisolid Products—Understanding the Impact of Metamorphosis on Skin Penetration and Physicochemical Properties" @default.
- W4309269323 cites W131700691 @default.
- W4309269323 cites W1967967402 @default.
- W4309269323 cites W1968770683 @default.
- W4309269323 cites W1989003191 @default.
- W4309269323 cites W1994266725 @default.
- W4309269323 cites W1996553985 @default.
- W4309269323 cites W1999610960 @default.
- W4309269323 cites W2002235617 @default.
- W4309269323 cites W2002685396 @default.
- W4309269323 cites W2003080384 @default.
- W4309269323 cites W2006573513 @default.
- W4309269323 cites W2007591700 @default.
- W4309269323 cites W2008876775 @default.
- W4309269323 cites W2012039647 @default.
- W4309269323 cites W2021621463 @default.
- W4309269323 cites W2023439288 @default.
- W4309269323 cites W2032557013 @default.
- W4309269323 cites W2042968208 @default.
- W4309269323 cites W2043941772 @default.
- W4309269323 cites W2045800643 @default.
- W4309269323 cites W2049191062 @default.
- W4309269323 cites W2050890076 @default.
- W4309269323 cites W2051026643 @default.
- W4309269323 cites W2055625108 @default.
- W4309269323 cites W2057463515 @default.
- W4309269323 cites W2067858340 @default.
- W4309269323 cites W2072446074 @default.
- W4309269323 cites W2075261045 @default.
- W4309269323 cites W2075924628 @default.
- W4309269323 cites W2080617238 @default.
- W4309269323 cites W2086884434 @default.
- W4309269323 cites W2089908828 @default.
- W4309269323 cites W2090783538 @default.
- W4309269323 cites W2091038441 @default.
- W4309269323 cites W2095491354 @default.
- W4309269323 cites W2096138335 @default.
- W4309269323 cites W2097510064 @default.
- W4309269323 cites W2101212670 @default.
- W4309269323 cites W2108730972 @default.
- W4309269323 cites W2110518646 @default.
- W4309269323 cites W2113862110 @default.
- W4309269323 cites W2124111070 @default.
- W4309269323 cites W2162853758 @default.
- W4309269323 cites W2765376601 @default.
- W4309269323 cites W2887982677 @default.
- W4309269323 cites W2888599335 @default.
- W4309269323 cites W2901818482 @default.
- W4309269323 cites W2944655780 @default.
- W4309269323 cites W3012573859 @default.
- W4309269323 cites W3022406184 @default.
- W4309269323 cites W3040911120 @default.
- W4309269323 cites W3045553188 @default.
- W4309269323 cites W3090027209 @default.
- W4309269323 cites W3170233241 @default.
- W4309269323 cites W3173228391 @default.
- W4309269323 cites W3177337151 @default.
- W4309269323 cites W3196002498 @default.
- W4309269323 cites W4206630950 @default.
- W4309269323 cites W4223481820 @default.
- W4309269323 cites W4224881271 @default.
- W4309269323 cites W4291901981 @default.
- W4309269323 cites W649209898 @default.
- W4309269323 cites W66361723 @default.
- W4309269323 cites W768236404 @default.
- W4309269323 doi "https://doi.org/10.3390/pharmaceutics14112487" @default.
- W4309269323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36432678" @default.
- W4309269323 hasPublicationYear "2022" @default.
- W4309269323 type Work @default.
- W4309269323 citedByCount "9" @default.
- W4309269323 countsByYear W43092693232023 @default.
- W4309269323 crossrefType "journal-article" @default.
- W4309269323 hasAuthorship W4309269323A5010374654 @default.
- W4309269323 hasAuthorship W4309269323A5051641480 @default.
- W4309269323 hasAuthorship W4309269323A5062328378 @default.
- W4309269323 hasBestOaLocation W43092693231 @default.
- W4309269323 hasConcept C127413603 @default.
- W4309269323 hasConcept C147789679 @default.
- W4309269323 hasConcept C159985019 @default.
- W4309269323 hasConcept C178790620 @default.
- W4309269323 hasConcept C183696295 @default.
- W4309269323 hasConcept C185592680 @default.
- W4309269323 hasConcept C187530423 @default.
- W4309269323 hasConcept C192562407 @default.
- W4309269323 hasConcept C200447597 @default.
- W4309269323 hasConcept C200990466 @default.
- W4309269323 hasConcept C2779820397 @default.
- W4309269323 hasConcept C2780035454 @default.
- W4309269323 hasConcept C2780449318 @default.
- W4309269323 hasConcept C41625074 @default.
- W4309269323 hasConcept C43617362 @default.